Aurora Cannabis (NYSE: ACB) Going Strong – What's Ahead for the Stock? - MJ Global Report
Connect with us

MJ Stocks

Aurora Cannabis (NYSE: ACB) Going Strong – What’s Ahead for the Stock?

Published

on

Aurora Cannabis

They say the one who sees things in the seed is a pure genius. When the legalization of marijuana started gathering some momentum back in the 90s, many investors saw the seed of opportunity in the cannabis plant. However, it’s only those that invested in the quality pot stocks have made a fortune.

But is it too late to benefit from the cannabis boom? Literally, it seems like the race has only just begun, but only if the right investments are chosen and focus is placed on the fundamentals.

The Canada-based grower’s stock Aurora Cannabis (NYSE: ACB) is poised for growth in 2019 and hence a stock to watch for most investors.

Aurora Cannabis Price Analysis

Headquartered in Edmonton, Canada, the company produces as well as distributes a wide variety of medical cannabis products. Aurora Cannabis is scheduled to report its third-quarter earnings shortly with expectations of a 3% loss on revenue of $55.1 million.

Currently, the stock’s price is at $11.38 having seen some decrease in the last few days. The price is steadily increasing as the shares shot up today by 5.6% bouncing off a 2-month low.

ACB price today.

Just recently, Aurora Cannabis Inc. fell by 3.95% from $8.35 to $8.02. However, it has hence picked up and risen with signs of an upward trend in the cards. Already, the company has broken broad as well as a strong rising short-term trend; hence as much as the rising trend may seem slow, it will surely get up.

Aurora Cannabis overview

Aurora is one of the leading cannabis companies in the world with a funded capacity of 625,000 kg marijuana annually and sales alongside the operations in more than 24 countries across 5 continents.

The company has an advanced consistent as well as efficient production strategy with its facilities built to meet the EU GMP standards.

It has been a hot pot stock especially this year and still has got a lot more room of reaching even higher.

Aurora’s Developments

Acquisitions play a significant role within the corporate ecosystem as they are the tools of expanding the revenue, competitive moats, profitability, and the geographical reach. In fact, shareholders are always eager of what the company will acquire next.

Aurora has not been left behind in wrapping up some acquisitions as well as they push forward. There were a series of acquisitions in 2017 and 2018, and this year started with acquiring Whistler Medical Marijuana in a deal worth $132 million.

The main reason for the acquisitions is to bridge the gap for more marijuana, and adding capacity is the best way.

Moreover, the company had taken over CanniMed Therapeutics – a leader in the Canadian medical marijuana industry. Further, it acquired the South American market leader, ICC Labs for $290 million which has proven to give Aurora a strong footprint in South America as well as a first mover advantage.

All the acquisitions are meant to make Aurora even better, and thus far they have proved to be supportive in the company’s journey.

What Raises Optimism?

Aurora announced its two facilities being fully licensed by the Canadian Health authority for production as well as the sale of marijuana. The two facilities: Aurora Sky and MedReleaf Bradford raised the stock’s price at the time.

So, it means that the stock has got great potential of moving up whenever an opportunity comes across. That is an aspect that keeps investors optimistic that Aurora stock is well on track to keep rising.

The Future Looks Bright for Aurora

Apart from benefiting from the location, Aurora looks to tie down a partnership with major beverage companies such as Coca-Cola so as to introduce cannabis-infused drinks.

Furthermore, the company has massively expanded its facilities to meet the high demand and has bought other firms. Notably, it acquired the Mexico-based medical marijuana partner, Farmacias Magistrales hence offering Aurora entry into the Mexican market.

Consequently, as much as Aurora has got its caveats, the stock looks bullish and with third-quarter earnings underway, the pot stock looks much attractive for the long-run.

For the latest updates on ACB and other MJ stocks, sign up below!

Disclosure: We have no position in ACB and have not been compensated for this article.

Photo by Sagui Andrea from Pexels

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

MJ Stocks

Hexo Stock (NYSE:HEXO): Is It A Buy Now?

Published

on

Hexo stock

A selloff in the broader cannabis sector that kicked off in earnest in summer has finally brought Hexo Stock (NYSE:HEXO) down to its lowest price in two years. Several factors contributed to the selloff in Canadian cannabis stocks in recent months.

One of them was uncertainty over Canada’s national election. Some investors feared Justin Trudeau would lose his re-election bid and herald difficult times for the cannabis industry.  The Trudeau administration has been very supportive of the cannabis industry in Canada.

The slow development of Canada’s regulated cannabis market weighed down by slow rollout of cannabis shops in provinces like Ontario also spooked investors, sparking a selloff in Canadian cannabis stocks. Hexo has no doubt been a victim of the selloff. But now the stock has bottomed out and looks poised for a powerful rebound.

Hexo stock closed up 14.5% in the last session, reversing a downtrend witnessed in the several previous sessions. Hexo’s gain in the last session came on big volume too, showing growing investor interest in the stock.

History repeats itself

Hexo stock has a history of bouncing back from the bottom. In late December of 2018, Hexo was trading at one of its lowest price levels at around $3. But the stock soon reversed course and sprinted to $6.10 by the start of February 2019, delivering a 103% return in a space of a little over one month.

By April,…

Continue Reading

MJ Stocks

GrowLife Stock (OTCMKTS:PHOT) Primed For Breakout And Here’s Why

Published

on

GrowLife stock

GrowLife stock (OTCMKTS:PHOT) has dropped significantly and currently trades at one of its lowest price levels in more than three years. At $0.002, the stock is 96% off its 3-year peak. The decline that has brought GrowLife this low kicked off in July and gained momentum in September.

If we look at GrowLife’s investor relations site and go to the press release section, we see that GrowLife has issued several updates on its business activities and developments since July. On July 11, GrowLife announced that it secured a patent for the design of its commercial cloning unit in Canada. GrowLife stated that the patent affirms that its commercial cloning design is not only effective but innovative and proprietary. GrowLife believes its patented commercial cloning design will greatly expand its growth opportunity given the increasing demand for hemp and cannabis clones amid ongoing cannabis legalization.

On August 12, GrowLife released its financial results for the first half of 2019 in which it revealed 82% year-over-year revenue growth. On September 13, GrowLife updated on its CBD hemp clone sales strategy. GrowLife intends to start selling clones next year.

However, none of these positive updates from GrowLife helped halt the slide in its stock. GrowLife stock now looks to have bottomed…

Continue Reading

MJ Stocks

Canopy Growth Corp (TSX:WEED) (NYSE:CGC) Charts Scream Buy Now

Published

on

Canopy Growth Corp

Canopy Growth Corp (TSX:WEED) (NYSE:CGC) is currently trading at one of its lowest price levels in two years. The decline in Canopy stock to the current lows can be attributed to two major issues: Canadian politics and the company’s financial performance in the latest quarter.

Investors generally shunned Canadian cannabis stocks in the run-up to the country’s national election in which incumbent Justin Trudeau faced a tough re-election challenge from a conservative candidate. Investors worried that a win for the conservatives could result in the rollback or a slow rollout of cannabis-friendly regulations. Since coming into power in 2015, the Trudeau administration has been supportive of Canada’s cannabis industry. That resulted in Canada becoming the first developed country to legalize cannabis for recreational use a year ago. Trudeau won the tough re-election contest last month, bringing reprieve to cannabis investors. However, Canadian cannabis stocks like Canopy are still trying to recover from the selloff sparked by fears over Canada’s national election.

As for Canopy, in particular, lackluster fiscal 2020 second-quarter results released last week added to the downward pressure on the stock. That saw the stock take a big plunge to its 2-year low last Friday (November 15).

About Canopy Growth Corp

Canopy is one of the top cannabis companies in Canada. It also has a presence in the hemp market. Moreover, Canopy boasts a significant international footprint in the regulated cannabis industry. Canopy…

Continue Reading

Enter Symbol For Report



MJ Stocks